Pharmacology Patisiran was approved by FDA recently for A Filariasis B Peripheral Neuropathy C Neuropathy of diabetes D Neuropathy of amyloidosis 💡 Explanation Patisiran was approved by FDA recently for ✓ Correct Answer: D. Neuropathy of amyloidosis